Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea
- Authors
- Baeg, Joo Yeong; Kim, In Hee; Seo, Seung Young; Kim, Young Seok; Jung, Eun Uk; Cho, Junhyeon; Chung, Jung Wha; Jang, Eun Sun; Kim, Jin Wook; Jeong, Sook-Hyang
- Issue Date
- May-2017
- Publisher
- 거트앤리버 발행위원회
- Keywords
- Hepacivirus; Depression; Interferons; Beck Depression Inventory-I; Hospital Anxiety and Depression scale
- Citation
- Gut and Liver, v.11, no.3, pp 426 - 433
- Pages
- 8
- Journal Title
- Gut and Liver
- Volume
- 11
- Number
- 3
- Start Page
- 426
- End Page
- 433
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7623
- DOI
- 10.5009/gnl16242
- ISSN
- 1976-2283
2005-1212
- Abstract
- Background/Aims: The association between depression and chronic hepatitis C virus (HCV) infection or pegylated interferon a and ribavirin therapy (PR therapy) has not been extensively studied in Korea. We aimed to clarify the prevalence of depression and its incidence during PR therapy in chronic hepatitis C (CHC) patients. Methods: In this prospective, multicenter study, 114 CHC patients were screened for depression using two self-reported scales, the Beck Depression Inventory-I(BDI-I) and the Hospital Anxiety and Depression scale (HADS). The incidence of depression during PR therapy was evaluated in 62 patients who underwent PR therapy during the study period. Results: The prevalence of baseline depression was 17.5% according to the BDI-I score >= 10 criterion and 4.4% according to the HADS-D score >= 8 criterion in the 114 CHC patients, and it was significantly associated with an unmarried state. During PR therapy, depression developed in 34.6% according to the BDI-I scale and 29.5% according to the HADS-D, which negatively affected sustained virologic response (SVR). Conclusions: The prevalence of depression in Korean CHC patients appears to be low compared to that in Western patients; however, its incidence during PR therapy (approximately 30%) was similar to that of other populations, which led to a lower SVR rate. Active screening and multidisciplinary management of depression during PR therapy is warranted.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7623)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.